Genetic risk factors for pediatric-onset multiple sclerosis

被引:35
作者
Gianfrancesco, Milena A. [1 ]
Stridh, Pernilla [2 ,3 ,4 ]
Shao, Xiaorong [1 ]
Rhead, Brooke [5 ]
Graves, Jennifer S. [6 ]
Chitnis, Tanuja [7 ]
Waldman, Amy [8 ]
Lotze, Timothy [9 ]
Schreiner, Teri [10 ]
Belman, Anita [11 ]
Greenberg, Benjamin [12 ]
Weinstock-Guttman, Bianca [13 ]
Aaen, Gregory [14 ]
Tillema, Jan M. [15 ]
Hart, Janace [6 ,16 ]
Caillier, Stacy [6 ,16 ]
Ness, Jayne [17 ,18 ]
Harris, Yolanda [17 ,18 ]
Rubin, Jennifer [19 ]
Candee, Meghan [20 ,21 ]
Krupp, Lauren [11 ]
Gorman, Mark [22 ]
Benson, Leslie [22 ]
Rodriguez, Moses [15 ]
Mar, Soe [23 ]
Kahn, Ilana [24 ]
Rose, John [25 ]
Roalstad, Shelly [26 ]
Casper, T. Charles [26 ]
Shen, Ling [27 ]
Quach, Hong [1 ]
Quach, Diana [1 ]
Hillert, Jan [28 ]
Hedstrom, Anna [28 ]
Olsson, Tomas [2 ,3 ,4 ]
Kockum, Ingrid [2 ,3 ,4 ]
Alfredsson, Lars [28 ,29 ]
Schaefer, Catherine [27 ,30 ]
Barcellos, Lisa F. [5 ,27 ,31 ]
Waubant, Emmanuelle [6 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Univ Calif Berkeley, Computat Biol Grad Grp, Berkeley, CA 94720 USA
[6] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[7] Massachusetts Gen Hosp Children, Partners Pediat Multiple Sclerosis Ctr, Boston, MA USA
[8] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
[9] Baylor Coll Med, Blue Bird Circle Multiple Sclerosis Ctr, Houston, TX 77030 USA
[10] Univ Colorado, Childrens Hosp Colorado, Denver, CO 80202 USA
[11] Stony Brook Childrens Hosp, Lourie Ctr Pediat MS, Stony Brook, NY USA
[12] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX USA
[13] SUNY Buffalo, Jacobs Neurol Inst, Pediat Multiple Sclerosis Ctr, Buffalo, NY USA
[14] Loma Linda Univ, Childrens Hosp, Pediat MS Ctr, Loma Linda, CA 92350 USA
[15] Mayo Clin, Pediat MS Ctr, Rochester, MN USA
[16] Univ Calif San Francisco, Reg Pediat MS Ctr, San Francisco, CA 94143 USA
[17] Univ Alabama Birmingham, Ctr Pediat Onset Demyelinating Dis, Birmingham, AL USA
[18] Childrens Hosp Alabama, Birmingham, AL USA
[19] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neurol, Chicago, IL 60611 USA
[20] Univ Utah, Salt Lake City, UT USA
[21] Primary Childrens Med Ctr, Salt Lake City, UT USA
[22] Boston Childrens Hosp, Boston, MA USA
[23] Washington Univ, Sch Med, Pediat Onset Demyelinating Dis & Autoimmune Encep, St Louis, MO USA
[24] Childrens Natl Med Ctr, Washington, DC 20010 USA
[25] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA
[26] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA
[27] Kaiser Permanente, Div Res, Oakland, CA USA
[28] Karolinska Inst, Inst Environm Med IMM, Stockholm, Sweden
[29] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden
[30] Kaiser Permanente, Res Program Genes Environm & Hlth, Oakland, CA USA
[31] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA
关键词
Multiple sclerosis; genetics; epidemiology; pediatrics; LOCUS; AGE; HLA-DRB1-ASTERISK-1501; ASSOCIATION; CRITERIA; TIME; SNP; MS;
D O I
10.1177/1352458517733551
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Strong evidence supports the role of both genetic and environmental factors in pediatric-onset multiple sclerosis (POMS) etiology. Objective: We comprehensively investigated the association between established major histocompatibility complex (MHC) and non-MHC adult multiple sclerosis (MS)-associated variants and susceptibility to POMS. Methods: Cases with onset <18 years (n = 569) and controls (n = 16,251) were included from the United States and Sweden. Adjusted logistic regression and meta-analyses were performed for individual risk variants and a weighted genetic risk score (wGRS) for non-MHC variants. Results were compared to adult MS cases (n = 7588). Results: HLA-DRB1*15:01 was strongly associated with POMS (odds ratio (OR)(meta) = 2.95, p < 2.0 x 10(-16)). Furthermore, 28 of 104 non-MHC variants studied (23%) were associated (p < 0.05); POMS cases carried, on average, a higher burden of these 28 variants compared to adults (ORavg = 1.24 vs 1.13, respectively), though the difference was not significant. The wGRS was strongly associated with POMS (ORmeta = 2.77, 95% confidence interval: 2.33, 3.32, p < 2.0 x 10(-16)) and higher, on average, when compared to adult cases. Additional class III risk variants in the MHC region associated with POMS were revealed after accounting for HLA-DRB1*15:01 and HLA-A*02. Conclusion: Pediatric and adult MS share many genetic variants suggesting similar biological processes are present. MHC variants beyond HLA-DRB1*15:01 and HLA-A*02 are also associated with POMS.
引用
收藏
页码:1825 / 1834
页数:10
相关论文
共 50 条
  • [1] Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans
    Langille, Megan M.
    Islam, Talat
    Burnett, Margaret
    Amezcua, Lilyana
    JOURNAL OF CHILD NEUROLOGY, 2016, 31 (08) : 1068 - 1073
  • [2] Multiple sclerosis risk factors contribute to onset heterogeneity
    Briggs, Farren B. S.
    Yu, Justin C.
    Davis, Mary F.
    Jiangyang, Jinghong
    Fu, Shannon
    Parrotta, Erica
    Gunzler, Douglas D.
    Ontaneda, Daniel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 11 - 16
  • [3] Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis
    Baroncini, Damiano
    Simone, Marta
    Iaffaldano, Pietro
    Brescia Morra, Vincenzo
    Lanzillo, Roberta
    Filippi, Massimo
    Romeo, Marzia
    Patti, Francesco
    Chisari, Clara Grazia
    Cocco, Eleonora
    Fenu, Giuseppe
    Salemi, Giuseppe
    Ragonese, Paolo
    Inglese, Matilde
    Cellerino, Maria
    Margari, Lucia
    Comi, Giancarlo
    Zaffaroni, Mauro
    Ghezzi, Angelo
    JAMA NEUROLOGY, 2021, 78 (06) : 726 - 735
  • [4] Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis
    Suleiman, Leena
    Waubant, Emmanuelle
    Aaen, Gregory
    Belman, Anita
    Benson, Leslie
    Candee, Meghan
    Chitnis, Tanuja
    Gorman, Mark
    Goyal, Manu
    Greenberg, Benjamin
    Harris, Yolanda
    Hart, Janace
    Kahn, Ilana
    Krupp, Lauren
    Lotze, Timothy
    Mar, Soe
    Moodley, Manikum
    Ness, Jayne
    Nourbakhsh, Bardia
    Rensel, Mary
    Rodriguez, Moses
    Rose, John
    Rubin, Jennifer
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Waldman, Amy
    Weinstock-Guttman, Bianca
    Casper, T. Charles
    Waltz, Michael
    Graves, Jennifer S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 22 : 103 - 107
  • [5] Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis
    Alroughani, Raed
    Ahmed, Samar F.
    Al-Hashel, Jasem
    PEDIATRIC NEUROLOGY, 2015, 53 (06) : 508 - 512
  • [6] A higher burden of multiple sclerosis genetic risk confers an earlier onset
    Misicka, Elina
    Davis, Mary F.
    Kim, Woori
    Brugger, Steven W.
    Beales, Jeremy
    Loomis, Stephanie
    Bronson, Paola G.
    Briggs, Farren B. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1189 - 1197
  • [7] Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature
    Jeong, Anna
    Oleske, Denise M.
    Holman, Joan
    JOURNAL OF CHILD NEUROLOGY, 2019, 34 (12) : 705 - 712
  • [8] Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis
    Sandesjo, Fredrik
    Alping, Peter
    Fink, Katharina
    Wickstrom, Ronny
    Piehl, Fredrik
    Frisell, Thomas
    Mckay, Kyla A.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2025, 11 (01)
  • [9] The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
    Greene, Nupur
    Araujo, Lita
    Campos, Cynthia
    Dalglish, Hannah
    Gibbs, Sarah
    Yermilov, Irina
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 103 - 114
  • [10] Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis
    Macaron, Gabrielle
    Feng, Jenny
    Moodley, Manikum
    Rensel, Mary
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (10)